Literature DB >> 30537868

Glia-immune interactions post-ischemic stroke and potential therapies.

Jessica Hersh1, Shao-Hua Yang1.   

Abstract

IMPACT STATEMENT: This article reviews glial cell interactions with the immune system post-ischemic stroke. Research has shown that glial cells in the brain play a role in altering phenotypes of other glial cells and have downstream immune cell targets ultimately regulating a neuroinflammatory response. These interactions may play a deleterious as well as beneficial role in stroke recovery. Furthermore, they may provide a novel way to approach potential therapies, since current stroke drug therapy is limited to only one Food and Drug Administration-approved drug complicated by a narrow therapeutic window. Until this point, most research has emphasized neuroimmune interactions, but little focus has been on bidirectional communication of glial-immune interactions in the ischemic brain. By expanding our understanding of these interactions through a compilation of glial cell effects, we may be able to pinpoint major modulating factors in brain homeostasis to maintain or discover ways to suppress irreversible ischemic damage and improve brain repair.

Entities:  

Keywords:  Ischemic stroke; T-cells; astrocytes; glial–immune interactions; glutamate; histamine; interleukin-15; microglia; monocytes; natural killer cells; neuroimmunology

Mesh:

Year:  2018        PMID: 30537868      PMCID: PMC6348596          DOI: 10.1177/1535370218818172

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  101 in total

1.  Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype.

Authors:  Sanjay K Garg; Ruma Banerjee; Jonathan Kipnis
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

2.  The impact of Ly6Clow monocytes after cerebral hypoxia-ischemia in adult mice.

Authors:  Jean-Philippe Michaud; Pedro Moreno Pimentel-Coelho; Yannick Tremblay; Serge Rivest
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

3.  Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

Authors:  Marie-Victoire Guillot-Sestier; Kevin R Doty; David Gate; Javier Rodriguez; Brian P Leung; Kavon Rezai-Zadeh; Terrence Town
Journal:  Neuron       Date:  2015-01-22       Impact factor: 17.173

4.  Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study.

Authors:  N Kostulas; S H Pelidou; P Kivisäkk; V Kostulas; H Link
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

5.  Aging enhances classical activation but mitigates alternative activation in the central nervous system.

Authors:  Daniel C Lee; Claudia R Ruiz; Lori Lebson; Maj-Linda B Selenica; Justin Rizer; Jerry B Hunt; Rahil Rojiani; Patrick Reid; Sidharth Kammath; Kevin Nash; Chad A Dickey; Marcia Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

6.  Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice.

Authors:  Sandra Giovanoli; Harald Engler; Andrea Engler; Juliet Richetto; Mareike Voget; Roman Willi; Christine Winter; Marco A Riva; Preben B Mortensen; Joram Feldon; Manfred Schedlowski; Urs Meyer
Journal:  Science       Date:  2013-03-01       Impact factor: 47.728

7.  Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model.

Authors:  Ross K Morgan; Brian McAllister; Lillian Cross; Daniel S Green; Hardy Kornfeld; David M Center; William W Cruikshank
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

8.  Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study.

Authors:  Atif Zafar; Asad Ikram; Dinesh V Jillella; Duraisamy Kempuraj; Mohammad Moshahid Khan; Saif Bushnaq; Harold Adam; Santiago Ortega-Gutierrez; Syed A Quadri; Mudassir Farooqui; Asgar Zaheer; Enrique C Leira
Journal:  Cureus       Date:  2017-10-11

9.  Histamine upregulates the expression of histamine receptors and increases the neuroprotective effect of astrocytes.

Authors:  Jiawen Xu; Xiang Zhang; Qingqing Qian; Yiwei Wang; Hongquan Dong; Nana Li; Yanning Qian; Wenjie Jin
Journal:  J Neuroinflammation       Date:  2018-02-13       Impact factor: 8.322

10.  Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.

Authors:  Sandra M Rocha; Tatiana Saraiva; Ana C Cristóvão; Raquel Ferreira; Tiago Santos; Marta Esteves; Cláudia Saraiva; Goun Je; Luísa Cortes; Jorge Valero; Gilberto Alves; Alexander Klibanov; Yoon-Seong Kim; Liliana Bernardino
Journal:  J Neuroinflammation       Date:  2016-06-04       Impact factor: 8.322

View more
  4 in total

Review 1.  Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection.

Authors:  Andrés Vicente-Acosta; Maria Ceprian; Pilar Sobrino; Maria Ruth Pazos; Frida Loría
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

2.  Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway.

Authors:  Xin Guan; Yunjie Wang; Guoyin Kai; Shunyi Zhao; Tingyu Huang; Youzhen Li; Yuan Xu; Luyong Zhang; Tao Pang
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

3.  Semi-Automated Cell and Tissue Analyses Reveal Regionally Specific Morphological Alterations of Immune and Neural Cells in a Porcine Middle Cerebral Artery Occlusion Model of Stroke.

Authors:  Samantha E Spellicy; Kelly M Scheulin; Emily W Baker; Brian J Jurgielewicz; Holly A Kinder; Elizabeth S Waters; Janet A Grimes; Steven L Stice; Franklin D West
Journal:  Front Cell Neurosci       Date:  2021-01-22       Impact factor: 5.505

Review 4.  Advances in 3D neuronal microphysiological systems: towards a functional nervous system on a chip.

Authors:  Wesley A Anderson; Alexander Bosak; Helena T Hogberg; Thomas Hartung; Michael J Moore
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-12       Impact factor: 2.416

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.